Cohanzick Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Cohanzick Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-67,827	Closed	-$677K	–	260
2022 Q3	$677K	Sell	67,827 -148	-0.2%	-$1.47K	0.16%	124
2022 Q2	$670K	Sell	67,975 -14,762	-18%	-$146K	0.19%	124
2022 Q1	$815K	Sell	82,737 -1,000	-1%	-$9.81K	0.18%	130
2021 Q4	$816K	Buy	83,737 +10,000	+14%	+$97.8K	0.14%	131
2021 Q3	$722K	Buy	73,737 +23,337	+46%	+$226K	0.17%	108
2021 Q2	$488K	Buy	+50,400	New	+$491K	0.15%	97

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohanzick Management's PKBO Position: Q4 2022 in Review

Cohanzick Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 67,827 shares — an estimated $677K sold.

Cohanzick Management first reported a position in PKBO in Q2 2021 and held it in 6 quarters. The position peaked at $816K in Q4 2021. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Cohanzick Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cohanzick Management sold 67,827 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $677K.
Cohanzick Management first reported a position in Peak Bio, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Cohanzick Management's Peak Bio, Inc. Common Stock position peaked at $816K in Q4 2021.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Cohanzick Management's 13F filing for Q4 2022, filed 13 Feb 2023.